Washington, DC 20006-5349
HELPLINE
(A version of this article was first published in the Mesothelioma Applied Research Foundation’s summer newsletter. The article has been updated with newly available information.)…
Since the beginning of the coronavirus pandemic, mesothelioma patients and their families have wanted to know how vulnerable they are to this novel virus. Over…
Today, the Mesothelioma Applied Research Foundation, among 130 organizations, cancer centers, and other institutions, sent a letter to President Joseph R. Biden, key members of…
The Mesothelioma Applied Research Foundation recommends Covid-19 vaccinations in mesothelioma patients receiving immunotherapy treatments. We commend the unprecedented development of safe, effective Covid-19 vaccines. It is our hope that these vaccines will end the pandemic, especially for our mesothelioma community…
Below, Dr. Taylor Ripley, a thoracic surgeon at Baylor and a member of the board of directors of the Mesothelioma Applied Research Foundation, takes a…
Today, the Mesothelioma Applied Research Foundation announced that it will fund three research projects in the field of mesothelioma for a total investment of $300,000…
Liz Darlison, head of services at Mesothelioma UK, spoke with Mary Hesdorffer, NP, about mesothelioma treatment in the United Kingdom during COVID-19 and in general. Liz is a…
Anna Nowak, MD, PhD, speaks about immunotherapy and combination of immunotherapy and chemotherapy for mesothelioma patients. She also discusses COVID-19’s effects on mesothelioma in treatment in Australia.…
Buerkley Rose, MSN, RN, discusses how the University of Chicago’s mesothelioma program has adapted during the COVID-19 pandemic: Clinical Trials: Paused. Telemedicine, including psycho-oncology services: Available. Surgery:…
Dr. R. Taylor Ripley discusses his research interests, diet and cancer, as well as seeking care and the mesothelioma program at Baylor College of Medicine during COVID-19: Telemedicine: Available…
Get the latest information about mesothelioma, clinical trials, patient stories, community events, and much more!
